Who
Christopher Martell
Director
Company insider
Files Form 4 as: Director, Candel Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 5
- Sells
- 0
- Bought
- $1.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 29 Jul 2021
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 25 Jun 2025filed 26 Jun 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code A | $520K111,349 at $4.67 | filing |
| 17 Jun 2025filed 18 Jun 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 28 Jun 2023filed 29 Jun 2023 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 9 Dec 2022filed 17 Feb 2023 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $46K23,950 at $1.92 | filing |
| 9 Dec 2022filed 12 Dec 2022 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $46K23,950 at $1.92 | filing |
| 8 Dec 2022filed 17 Feb 2023 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,1243,050 at $1.68 | filing |
| 8 Dec 2022filed 12 Dec 2022 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,1243,050 at $1.68 | filing |
| 13 Oct 2022filed 17 Oct 2022 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 29 Jul 2021filed 2 Aug 2021 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code C | —283,514 | filing |
| 29 Jul 2021filed 2 Aug 2021 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $1.0M125,000 at $8.00 | filing |
| 29 Jul 2021filed 2 Aug 2021 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —696,851 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.